Answers are grounded in this paper and cite their sources.
Observational analysis reveals increased severity of ischemic stroke in young women using oral contraceptives, indicating potential health risks.
Combined oral contraceptives (OCs) are female hormonal drugs that contain estrogen and progesterone. They have been available for more than 50 years, and the impact of this invention is hard to overestimate. Today, more than 100 million women use them, and in Western Europe and the United States, about 80% of women of reproductive age can be considered to have ever used them. However, the use of OCS, like any hormonal drugs, is associated with a risk of complications. One of the most serious is ischemic stroke.Estrogens are a group of steroid hormones that are naturally synthesized in the ovaries and exist in three forms: estrone, estradiol and estriol. It has been established that estrogens, by binding to receptors which are located in various tissues, including the brain parenchyma, have not only a positive effect. The effect of estrogen on the vascular wall structure has a potentially harmful effect: prothrombotic and proinflammatory. This occurs by stimulating of endothelial cells growth and inhibition of smooth muscle cells proliferation, which leads to thickening and decreased elasticity of the blood vessel wall.The objective: to analyze the effect of OC use on the severity of ischaemic stroke in young women.Materials and methods. 45 women in the acute period of cerebral ischemic stroke aged 19 to 35 years (mean age – 27.2 ± 1.6 years) were examined at the Department of Cerebrovascular Pathology of Municipal non-profit enterprise “St. Michael’s Clinical Hospital of Kyiv” from 2017 to 2024. The patients were divided into two groups: I group – 30 women who took OCs, and II group (control one) – 15 women who did not use OCs in history. At the time of hospitalization, all patients in I group were taking OCs in a dosage of no more than 3 mg of estrogen per day and 3 mg of progestogens. The duration of OC use was on average from 6 months to 1 year. Only one patient had a history of OC discontinuation 3 months before hospitalization. The severity of neurological deficit was assessed using the National Institutes of Health Stroke Scale (NIHSS).Results. In I group 15 (50.5%) patients had the following risk factors for ischaemic stroke: in 2 (6.6%) patients – congenital heart disease (an open oval window up to 2.5 mm); in 4 (13.3%) – active smoking (at least 10 cigarettes per day); in 2 (6.6%) – elevated levels of total cholesterol, low-density lipoproteins, triglycerides, atherogenicity index; in 2 (6.6%) – blood pressure higher than 140/90 mmHg at the time of hospitalization, but not higher than 150/90 mmHg, without the history of arterial hypertension (AH) diagnosis; in 4 (13.3%) – migraine without aura; in 1 (3.3%) – atrial fibrillation, and in 1 (3.3%) – obesity. Atherosclerotic lesions of brachiocephalic vessels, coronary heart disease (CHD), diabetes mellitus (DM) were not detected in I group.In I group 12 (80.3%) patients had the following risk factors: 10 (66.6%) patients had AH; 7 (46.6%) – atherosclerosis with dyslipidaemia; 5 (33.3%) – CHD; 5 (33.3%) – atrial fibrillation; 2 (13.3%) – DM; 4 (26.6%) – obesity; 5 (33.3%) – a history of smoking. A history of congenital heart defects and migraine was not detected in patients of II group.There was a significant increase in neurological deficit according to the NIHSS: in I group – 12.1 ± 2.3 points, which corresponds to moderate stroke, in II group – 4.3 ± 3.6 points, which corresponds to mild stroke (p < 0.05).Conclusions. The use of OCs in young women with of risk factors such as arterial hypertension, dyslipidaemia, obesity, smoking, atrial fibrillation, open oval window, and migraine affects the severity of ischaemic stroke.
No takes yet. Share an insight, caveat, or question.
Trepet et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: